Hybrid immunity improves B cells and antibodies against SARS-CoV-2 variants

The emergence of SARS-CoV-2 variants is jeopardizing the effectiveness of current vaccines and limiting the application of monoclonal antibody-based therapy for COVID-19 (refs. (1,2)). Here we analysed the memory B cells of five naive and five convalescent people vaccinated with the BNT162b2 mRNA va...

Descripción completa

Detalles Bibliográficos
Autores principales: Andreano, Emanuele, Paciello, Ida, Piccini, Giulia, Manganaro, Noemi, Pileri, Piero, Hyseni, Inesa, Leonardi, Margherita, Pantano, Elisa, Abbiento, Valentina, Benincasa, Linda, Giglioli, Ginevra, De Santi, Concetta, Fabbiani, Massimiliano, Rancan, Ilaria, Tumbarello, Mario, Montagnani, Francesca, Sala, Claudia, Montomoli, Emanuele, Rappuoli, Rino
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8674140/
https://www.ncbi.nlm.nih.gov/pubmed/34670266
http://dx.doi.org/10.1038/s41586-021-04117-7

Ejemplares similares

Ejemplares similares